Literature DB >> 15221874

Painful peripheral neuropathy and its nonsurgical treatment.

Gil I Wolfe1, Jaya R Trivedi.   

Abstract

Treatment of neuropathic pain is the primary focus of management for many patients with painful peripheral neuropathy. Antidepressants and anticonvulsants are the two pharmacological classes most widely studied and represent first-line agents in the management of neuropathic pain. The number of pharmacological agents that have demonstrated effectiveness for neuropathic pain continues to expand. In the current review, we summarize data from randomized, controlled pharmacological trials in painful peripheral neuropathies. Although neuropathic pain management remains challenging because the response to therapy varies considerably between patients, and pain relief is rarely complete, a majority of patients can benefit from monotherapy using a well-chosen agent or polypharmacy that combines medications with different mechanisms of action.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15221874     DOI: 10.1002/mus.20057

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  15 in total

1.  Management of painful neuropathies.

Authors:  Harry J Gould
Journal:  Curr Treat Options Neurol       Date:  2007-03       Impact factor: 3.598

2.  Paclitaxel inhibits the activity and membrane localization of PKCα and PKCβI/II to elicit a decrease in stimulated calcitonin gene-related peptide release from cultured sensory neurons.

Authors:  Lisa M Darby; Hongdi Meng; Jill C Fehrenbacher
Journal:  Mol Cell Neurosci       Date:  2017-04-09       Impact factor: 4.314

3.  Depression-like behavior and mechanical allodynia are reduced by bis selenide treatment in mice with chronic constriction injury: a comparison with fluoxetine, amitriptyline, and bupropion.

Authors:  Cristiano R Jesse; Ethel A Wilhelm; Cristina W Nogueira
Journal:  Psychopharmacology (Berl)       Date:  2010-08-06       Impact factor: 4.530

4.  Prevalence and treatment of depression in children and adolescents with sickle cell disease: a retrospective cohort study.

Authors:  Jeanette M Jerrell; Avnish Tripathi; Roger S McIntyre
Journal:  Prim Care Companion CNS Disord       Date:  2011

Review 5.  [Treatment options in painful diabetic polyneuropathy].

Authors:  Juan J Archelos
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

6.  Prevalence and characterization of neuropathic pain in a primary-care setting in Spain: a cross-sectional, multicentre, observational study.

Authors:  Concepción Pérez; María Teresa Saldaña; Ana Navarro; Inma Vilardaga; Javier Rejas
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

7.  Effect of Aerobic Exercise Training on Mood in People With Traumatic Brain Injury: A Pilot Study.

Authors:  Ali A Weinstein; Lisa M K Chin; John Collins; Divya Goel; Randall E Keyser; Leighton Chan
Journal:  J Head Trauma Rehabil       Date:  2017 May/Jun       Impact factor: 2.710

8.  Immortalization and characterization of a nociceptive dorsal root ganglion sensory neuronal line.

Authors:  Weiran Chen; Ruifa Mi; Norman Haughey; Murat Oz; Ahmet Höke
Journal:  J Peripher Nerv Syst       Date:  2007-06       Impact factor: 3.494

9.  Effects of paroxetine and sertraline on low-density lipoprotein cholesterol: an observational cohort study.

Authors:  Feifei Wei; A Lauren Crain; Robin R Whitebird; Olga V Godlevsky; Patrick J O'Connor
Journal:  CNS Drugs       Date:  2009-10       Impact factor: 5.749

Review 10.  Overview on pathophysiology and newer approaches to treatment of peripheral neuropathies.

Authors:  Alessandra Vanotti; Maurizio Osio; Enrico Mailland; Caterina Nascimbene; Elisa Capiluppi; Claudio Mariani
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.